We are live on
!
Find out more
Sana Biotechnology
SANA
SANA
117 hedge funds and large institutions have $986M invested in Sana Biotechnology in 2022 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 42 increasing their positions, 26 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
100% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 12
62% more repeat investments, than reductions
Existing positions increased: 42 | Existing positions reduced: 26
11% more funds holding
Funds holding: 105 → 117 (+12)
3.92% more ownership
Funds ownership: 59.08% → 63% (+3.9%)
4% less call options, than puts
Call options by funds: $136K | Put options by funds: $141K
43% less capital invested
Capital invested by funds: $1.73B → $986M (-$741M)
60% less funds holding in top 10
Funds holding in top 10: 5 → 2 (-3)
Holders
117
Holders Change
+12
Holders Change %
+11.43%
% of All Funds
1.85%
Holding in Top 10
2
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-60%
% of All Funds
0.03%
New
24
Increased
42
Reduced
26
Closed
12
Calls
$136K
Puts
$141K
Net Calls
-$5K
Net Calls Change
+$108K
Top Buyers
| 1 |
State Street
Boston,
Massachusetts
|
+$29.2M |
| 2 |
WP
Woodline Partners
San Francisco,
California
|
+$8.64M |
| 3 |
Morgan Stanley
New York
|
+$8.53M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$6.84M |
| 5 |
Renaissance Technologies
New York
|
+$6.33M |
